JPS5841894A - Sangenone - Google Patents

Sangenone

Info

Publication number
JPS5841894A
JPS5841894A JP56141310A JP14131081A JPS5841894A JP S5841894 A JPS5841894 A JP S5841894A JP 56141310 A JP56141310 A JP 56141310A JP 14131081 A JP14131081 A JP 14131081A JP S5841894 A JPS5841894 A JP S5841894A
Authority
JP
Japan
Prior art keywords
sangenone
soluble
extract
methanol
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56141310A
Other languages
Japanese (ja)
Other versions
JPH0228597B2 (en
Inventor
Taro Nomura
太郎 野村
Kimitomo Yoshioka
君友 吉岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zenyaku Kogyo KK
Original Assignee
Zenyaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zenyaku Kogyo KK filed Critical Zenyaku Kogyo KK
Priority to JP56141310A priority Critical patent/JPS5841894A/en
Publication of JPS5841894A publication Critical patent/JPS5841894A/en
Publication of JPH0228597B2 publication Critical patent/JPH0228597B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

NEW MATERIAL:A sangenone having physical and chemical properties as follows (sangenone D): description: yellow powder, molecular weight: 708 (according to the field desorption mass spectrography), melting point: 175-185 deg.C (decomposed), [alpha]D<25>=-145 deg. (c=0.173 in methanol); positive to ferric chloride reaction and to hydrochloric acid-magnesium reaction, hard soluble in water, hexane, chloroform, soluble in ethyl ether or ethyl acetate, easy soluble in methanol, ethanol, DMF, acetone; acidic substance. USE:Hypotensor with low toxicity. PREPARATION:For example, barks of mulberry tree roots are finely cut, defatted with a low-polarity organic solvent, then extracted with a lower alcohol. The extract is filtered, the filtrate is dried under reduced pressure to obtain an extract. The extract is subjected to column chromatography to separate impurities and collect fractions containing sangenone D. Then, sangenone is isolated and purified.

Description

【発明の詳細な説明】 本発明は血圧下降作用を有し、医薬として有用な新規化
合物(サンゲノンD)に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel compound (Sangenone D) that has a blood pressure lowering effect and is useful as a pharmaceutical.

これまで、桑根皮については漢方において桑白皮と称し
、消炎性利尿、緩下、鎮咳去痰剤として漢方製剤に配合
されている。
Until now, mulberry root bark has been referred to as mulberry white bark in Chinese medicine, and has been included in Chinese medicine preparations as an anti-inflammatory diuretic, laxative, and antitussive expectorant.

また最近では、そのメタノールエキスの血圧下降作用(
日本薬学会第99年会講演、要旨集、162頁、29A
2−3 )、エキス抽出物の過血糖降下作用(特公昭5
3−44530号公報)、エキス中ニt fしている高
分子多糖体のインターフェロン誘起作用(特開昭53−
99313号公報)等が知られている。
Recently, the blood pressure lowering effect of methanol extract (
99th Annual Meeting of the Pharmaceutical Society of Japan, Abstracts, 162 pages, 29A
2-3), Hyperglycemic lowering effect of extract (Tokuko Sho 5)
3-44530), interferon-inducing effect of high molecular weight polysaccharide in extract (Japanese Patent Application Laid-Open No. 1983-1999)
99313) etc. are known.

しかしながら、血圧下降作用における活性本体について
は、発明者等が発見した本邦産桑根皮中の2種の8−置
換シクロヘキセニルフラボン誘導体クワノンG及びクワ
ノンH(ケミカルアンドファーマシューテイ力ル プレ
ティン(Chem。
However, regarding the active substance in the blood pressure lowering effect, two types of 8-substituted cyclohexenylflavone derivatives, quanon G and quanon H (Chemical and Pharmaceutical Pretin (Chem. .

Pharm、Bull、) 28巻、8号、2548頁
(1980年)、ヘテロサイクルズ(、HETEROC
YCLES)14巻、12号、1943頁(1980年
)〕以外未だ解明されていない。
Pharm, Bull, ) Vol. 28, No. 8, p. 2548 (1980), Heterocycles (, HETEROC
YCLES, Vol. 14, No. 12, p. 1943 (1980)] have not yet been elucidated.

本発明者等は、鋭意研究の結果、クワ科りワ属(Mor
tLs )植物を有機溶媒で抽出し、この抽出エキスよ
り単離して得られた新規化合物に血圧下降作用があるこ
とを見出して本発明を完成し・これをサンゲノンDと命
名した。
As a result of intensive research, the present inventors have discovered that the family Moraceae (Moraceae)
tLs) The present invention was completed by extracting plants with an organic solvent, and discovering that a new compound obtained by isolating from this extract had a blood pressure lowering effect, and named it Sangenone D.

まず、サンゲノンDの製造法について説明する。First, the method for producing Sangenone D will be explained.

桑根皮を細切し、比較的極性の小さい有機溶媒で脱脂処
理を行った後、低級アルコール、低Mk 脂肪酸エステ
ル、エーテル又はアセトンで抽出r゛過し、P液を減圧
乾燥して抽出エキスを得、この抽出エキスを常法に従い
カラムクロマトグラフィーに付し不純物を分離し、サン
ゲノンDを含む画分を得る。次いで、この両分を分取薄
層クロマトグラフィー或は高速液体クロマトグラフィー
に付し、単離精製してサンゲノンDを製造する。
Mulberry root bark is cut into small pieces, degreased with a relatively non-polar organic solvent, extracted with lower alcohol, low Mk fatty acid ester, ether or acetone, filtered, and the P liquid is dried under reduced pressure to obtain an extracted extract. This extracted extract is subjected to column chromatography according to a conventional method to separate impurities, and a fraction containing Sangenone D is obtained. Next, these two fractions are subjected to preparative thin layer chromatography or high performance liquid chromatography to isolate and purify them to produce Sangenone D.

ここで、原料である桑は中国産の市販薬白皮、マグワ(
Moruv alba L、)、ヤマグワ(MorLL
s bambycisKoidz )或はロソウ(Mo
rus LhoLLKoidz又はMorwmulti
caulis Perr、 )等が用いられ、特にその
根皮が好ましい。これらは充分乾燥した細末とする。
Here, the raw material, mulberry, is used as a commercially available medicine from China such as white bark and magwa (
Moruv alba L,), Yamaguwa (MorLL)
s bambycisKoidz) or Rosou (Mo
rus LhoLLKoidz or Morwmulti
caulis perr, ), etc., and its root bark is particularly preferred. These should be thoroughly dried into fine powders.

脱脂処理に使用する比較的極性の小さい有機溶媒として
はn−へキサン、ベンゼン等が適する。
Suitable organic solvents with relatively low polarity for use in the degreasing treatment include n-hexane and benzene.

711用の低級アルコールとしてはメタノール、エタノ
ール等が、低級脂肪酸エステルとしては酢酸メチル、酢
酸エチル、酢酸ブチル等が、エーテルとしてはメチルエ
ーテル、エチルエーテル等が使用可能である。
As the lower alcohol for 711, methanol, ethanol, etc. can be used, as the lower fatty acid ester, methyl acetate, ethyl acetate, butyl acetate, etc. can be used, and as the ether, methyl ether, ethyl ether, etc. can be used.

常法によるカラムクロマトグラフィーとしては、例えば
、シリカゲルを充填したカラムを用いて、アセトン−ベ
ンゼン混液、メタノール−ベンゼン混液、酢酸エチル−
ベンゼン混液、又はアセトン−ルーへキサン混液で溶出
することによりサンゲノンDを含む画分を得ることがで
きる。
For column chromatography using a conventional method, for example, using a column packed with silica gel, acetone-benzene mixture, methanol-benzene mixture, ethyl acetate-
A fraction containing Sangenone D can be obtained by elution with a benzene mixture or an acetone-hexane mixture.

次いで行なう精製操作については、例えば、シリカゲル
分取薄層クロマトグラフィーでヘキサン、ベンゼン、エ
チルエーテル、クロロホルム、アセトン、酢酸エチル文
はメタノール等の溶媒を゛単独で又は混合して用いて展
開し分取することにより、或はこの操作を繰り返すこと
により、サンゲノンDを得ることができる。
For the subsequent purification operation, for example, hexane, benzene, ethyl ether, chloroform, acetone, and ethyl acetate are developed by preparative thin layer chromatography on silica gel using a solvent such as methanol alone or in combination, and then preparatively separated. Sangenone D can be obtained by doing this or by repeating this operation.

なお、上記抽出・分離操作中、脱脂処理を省略すること
も可能である。
Note that it is also possible to omit the degreasing treatment during the above extraction/separation operation.

上記の如く処理して得られるサンゲノンDの物理的及び
化学的性質は次のとおりである。
The physical and chemical properties of Sangenone D obtained by the above treatment are as follows.

(a)性 状:黄色粉末 (A)分子ffi: 708 (フィールド デソープ
ション マススペクトルのM+より) (C)融 点:175〜185℃(分解)(d)瓦旋光
度:〔α席−145°(C=0.173、メタノール)
(e)赤外吸収スペクトル(nu、)’ol ) (c
Fn″″1)(第1図参照)シmaヨ:3200.16
65 (sh )、1645 (sh )、1620 
、(br、)、1555(sA)(イ)紫外吸収スペク
トル(njn)(第2図参照)′λ、933H(log
 g ) : 220 (Eh、 4.65 )、22
6 (、rA、4.57 )、283 (4,33)、
288 (Sh、 4.32 )、309 (4,30
) λ0H30H+A′。′3(eOgε):225(4,
62)、292 (JA、4.28)、ax 309 (4,39)、352 (Sk、3.94 )
、400 (、rA、3.38 ) (y)核磁気共鳴スペクトル(d6−DMSO1200
MHz、 120°)(711F)δ: 1.37(3
H,s )、1.43(3H,、r)、1.67(3H
,s)、1.90−2.20(IH,m )、2.30
〜2.50 (IH,m )、2.59(IHSddX
J=7.14Hz )、2.89(10,ddXJ=B
、14Hz )、3.52(I)−1、ddd、 J=
4.11.11JIz)、4.26(IHXbr、 d
、 J =11Hz)、4.78(IH,t、J =l
lHz)、5.09(IHlm)、5.16(IH,b
r、 JP )、5.88(IHXs )、5.96(
IH,d、 J=2Hz)、5.98(l)(、dd、
J=2.8Hz)、6.05 (IHXdd、 J=2
.8Hす、6.14(IH,dXJ=2Hす、6.31
 (IHXd、 J=2Hz)、641(川、dd、 
J=2.8Hす、6.76(IHXd、 J=8Hz)
、7.20(IH,d、 J=8Hz)、7.60(I
H,d、J=8Hz) (勾呈色反応 塩化第二鉄反応      陽性(赤紫色)塩酸−マグ
ネシウム反応     陽性(橙 色)水素化ホウ素ナ
トリウム反応     陽性(橙 色)(’)分子式:
 C40H36o12 0)溶媒に対する溶解性 11溶:水、ヘキサン、ベンゼン、クロロホルム、ジク
ロロメタン 可溶 :エチルエーテル、酢酸エチル 易溶 : メタノール、エタノール、ジメチルホルムア
ミド、アセトン (k)酸性、中性、塩基性の区別:酸性上記サンゲノン
Dの強圧下降作用は以下に示す動°物実験により確認し
た。
(a) Properties: Yellow powder (A) Molecule ffi: 708 (from M+ field desorption mass spectrum) (C) Melting point: 175-185°C (decomposition) (d) Optical rotation: [α seat- 145° (C=0.173, methanol)
(e) Infrared absorption spectrum (nu, )'ol ) (c
Fn″″1) (See Figure 1) Size: 3200.16
65 (sh), 1645 (sh), 1620
, (br,), 1555 (sA) (a) Ultraviolet absorption spectrum (njn) (see Figure 2)'λ, 933H (log
g): 220 (Eh, 4.65), 22
6 (, rA, 4.57), 283 (4,33),
288 (Sh, 4.32), 309 (4,30
) λ0H30H+A'. '3(eOgε):225(4,
62), 292 (JA, 4.28), ax 309 (4,39), 352 (Sk, 3.94)
, 400 (, rA, 3.38) (y) Nuclear magnetic resonance spectrum (d6-DMSO1200
MHz, 120°) (711F) δ: 1.37 (3
H,s ), 1.43(3H,,r), 1.67(3H
, s), 1.90-2.20 (IH, m), 2.30
~2.50 (IH,m), 2.59 (IHSddX
J=7.14Hz), 2.89(10, ddXJ=B
, 14Hz), 3.52(I)-1, ddd, J=
4.11.11JIz), 4.26 (IHXbr, d
, J = 11 Hz), 4.78 (IH,t, J = l
lHz), 5.09 (IHlm), 5.16 (IH,b
r, JP), 5.88 (IHXs), 5.96 (
IH, d, J=2Hz), 5.98(l)(, dd,
J=2.8Hz), 6.05 (IHXdd, J=2
.. 8H, 6.14 (IH, dXJ=2H, 6.31
(IHXd, J=2Hz), 641 (kawa, dd,
J=2.8H, 6.76 (IHXd, J=8Hz)
, 7.20 (IH, d, J=8Hz), 7.60 (I
H, d, J = 8Hz) (Gradient color reaction Ferric chloride reaction Positive (reddish purple) Hydrochloric acid-magnesium reaction Positive (orange) Sodium borohydride reaction Positive (orange) (') Molecular formula:
C40H36o12 0) Solubility in solvents 11 Soluble: Water, hexane, benzene, chloroform, dichloromethane Soluble: Ethyl ether, ethyl acetate Easily soluble: Methanol, ethanol, dimethylformamide, acetone (k) Distinction between acidic, neutral, and basic : The strong pressure-lowering effect of the acidic Sangenone D was confirmed by the following animal experiment.

まず試料をエタノール及びプロピレングリコールにて溶
解し、生理食塩水で希釈することによりl y19/m
lに調製して、麻酔下〔ベンドパルビタール゛ao m
y/kg(す)及びウレタン1.5 g/に!?(J?
C) )でウィスター系ラット(雄性、体重350〜4
00g)及び自然発生高血圧ラツ)(SHR)(jI性
、体重200〜230g)に後肢静脈投与して総頚動脈
よりポリグラフにて畝面的に血圧を測定した。
First, the sample was dissolved in ethanol and propylene glycol, and diluted with physiological saline.
Bendoparbital ao m was prepared under anesthesia.
y/kg (su) and urethane 1.5 g/! ? (J?
C) Wistar rats (male, weight 350-4
00g) and spontaneously hypertensive rats (SHR) (JI, weight 200-230g) were administered into the hind limb vein, and blood pressure was measured using a polygraph from the common carotid artery.

その結果、ウィスター系ラットでは1897に9の投与
量で35vmHy又、SHRでは1 my/kg ノ投
与量で8011H,9の血圧下降が見られた。
As a result, in Wistar rats, a decrease in blood pressure of 35 vmHy was observed at a dose of 1897/9, and in SHR, a decrease in blood pressure of 8011H,9 was observed at a dose of 1 my/kg.

又、急性毒性におけるLD50はマウス(5週齢、dd
Y系、雄性)M腔内投与で300IIg/kg以上であ
つ 〜た。
In addition, the LD50 for acute toxicity was determined in mice (5 weeks old, dd
Y strain, male) M intracavitary administration was 300 IIg/kg or more.

以上述べたように、前記の物理的及び化学的性質を有す
るサンゲノンDは、桑根皮より比較的簡単な抽出精製操
作により製造することができ、又、優れた血圧下降作用
を示し、しかも毒性が低いので降圧剤として好適である
As mentioned above, Sangenone D, which has the above-mentioned physical and chemical properties, can be produced from mulberry root bark through a relatively simple extraction and purification procedure, exhibits an excellent blood pressure lowering effect, and is also toxic. It is suitable as an antihypertensive agent because of its low antihypertensive properties.

以下に本発明のサンゲノン化合物(サンゲノンD)の製
造法を具体的に説明する。
The method for producing the Sangenone compound (Sangenone D) of the present invention will be specifically explained below.

製造例 細切した乾燥市販薬根皮(中国広東省産)8kgをn−
ヘキサン40/で2回、更にベンゼン40/で2回、い
ずれも室温で1週間脱脂処理し、次いでメタノール40
/で2回、室温で各3日間抽出を行ない、抽出液をr取
し、減圧上溶媒を留去した後、酢酸エチル11を加え、
可溶部を分取した。
Production example: 8 kg of shredded dried commercially available medicinal root bark (produced in Guangdong, China) was
Degreased twice with 40/hexane and then twice with 40/benzene at room temperature for one week, then with 40% methanol.
Extraction was carried out twice at room temperature for 3 days each, the extract was collected, the solvent was distilled off under reduced pressure, and ethyl acetate 11 was added.
The soluble portion was separated.

この酢酸エチル可溶部より減圧上溶媒を留去し、抽出エ
キス70.9を得た。
The solvent was distilled off under reduced pressure from this ethyl acetate soluble portion to obtain an extracted extract of 70.9%.

この抽出エキス36.9を必要最少量のアセトンに溶解
し、シリカゲル(ワコーゲルc−2oo、和光純薬工業
製)7(L9に吸着させ、溶媒を蒸発除去した後、シリ
カゲル300.9を充填したカラムの上に層積充填し、
まず15チアセトンーベンゼンを展開溶媒として10/
溶出して夾雑物、を除去した後、20チアセトンーベン
ゼン5/にて溶出し、この溶出液を減圧濃縮してサンゲ
ノンDを含む両分113.0 、li’を得た。
This extract 36.9 was dissolved in the minimum necessary amount of acetone and adsorbed onto silica gel (Wakogel C-2OO, manufactured by Wako Pure Chemical Industries, Ltd.) 7 (L9). After the solvent was removed by evaporation, silica gel 300.9 was filled. Layer packing on top of the column,
First, 10/15 thiacetone-benzene was used as a developing solvent.
After removing impurities by elution, elution was carried out with 20 thiacetone-benzene 5/5, and this eluate was concentrated under reduced pressure to obtain two fractions containing Sangenone D, 113.0, li'.

この画分を分取薄層クロマトグラフィー〔ワコーゲルB
−5F(和光紬薬工業製)、展開溶媒;メタノール:ク
ロロホルム=1:5、アセトン:へキサン=1:1、エ
チルエーテルのみ(ri次)〕で精製し、サンジノンI
)t、oyを得た。その物理的及び化学的性質は下記の
通りであった。
This fraction was subjected to preparative thin layer chromatography [Wakogel B
-5F (manufactured by Wako Tsumugi Kogyo Co., Ltd.), developing solvent: methanol: chloroform = 1:5, acetone: hexane = 1:1, ethyl ether only (ri next)], and Sandinone I
)t,oy was obtained. Its physical and chemical properties were as follows.

(α)性 状:黄色粉末 (h)分子量: 708(フィールド デソープション
 マススペクトルのM+より) (C)融 点:175〜185℃(分解)(dl比旋光
度: 〔α〕”−145°(C=0.173、メタノー
ル)(e)赤外吸収スペクトル(nu)’ot )  
(cm−’ )νm(1,z : 320Q、1665
(tA)、1645(SA)、1620(br、)、1
555(SA) げ)紫外吸収スペクトル(1L) λOH3°H(C09’ ) : 220(yA、 4
.65)、226(Sk、 4.57)、ax 283(、−4,33)、288(、rA、 4.32
)、309(4,30) λOH3°”””’ (log ff) : 225(
4,62)、292(sh、4.28)、309(4,
39)、352(、tA、 3.94)、400(、r
A、3.38) (y)呈色反応 塩化第二鉄反応       陽性(赤紫色)塩醗−マ
グネシウム反応      陽性(橙 色)水素化ホウ
素ナトリウム反応      陽性(橙 色)(A)溶
媒に対する溶解性 all:  水、ヘキサン、ベンゼン、クロロホルム、
ジクロロメタン 可溶 : エチルエーテル、酢酸エチル易溶:  メタ
ノール、エタノール、ジメチルホルムアミド、アセトン (L)#性、中性、塩基性の区別:酸性0)元素分析値 実験値(チ); C: 64.75、H:5.20(k
)R7値〔シリカゲル薄層クロマトグラフィー(和光紬
薬工業製:ワコーゲルB−5F)) 0.31(メタノミル:如ロホルム−1:5)0.61
(アセトン:ベンゼン−1:1)
(α) Properties: Yellow powder (h) Molecular weight: 708 (from M+ field desorption mass spectrum) (C) Melting point: 175-185°C (decomposition) (dl specific optical rotation: [α]”-145 °(C=0.173, methanol) (e) Infrared absorption spectrum (nu)'ot)
(cm-') νm(1,z: 320Q, 1665
(tA), 1645 (SA), 1620 (br,), 1
555 (SA) UV absorption spectrum (1L) λOH3°H (C09'): 220 (yA, 4
.. 65), 226 (Sk, 4.57), ax 283 (, -4,33), 288 (, rA, 4.32
), 309(4,30) λOH3°"""' (log ff): 225(
4,62), 292(sh, 4.28), 309(4,
39), 352 (,tA, 3.94), 400(,r
A, 3.38) (y) Color reaction Ferric chloride reaction Positive (reddish purple) Salt-magnesium reaction Positive (orange) Sodium borohydride reaction Positive (orange) (A) Solubility in solvents all : Water, hexane, benzene, chloroform,
Soluble in dichloromethane: Ethyl ether, ethyl acetate Easily soluble: Methanol, ethanol, dimethylformamide, acetone (L) #Distinction between neutrality and basicity: Acidic 0) Elemental analysis value Experimental value (H); C: 64. 75, H: 5.20 (k
) R7 value [Silica gel thin layer chromatography (Wako Tsumugi Kogyo Co., Ltd.: Wakogel B-5F)] 0.31 (Methanomyl: Nyoroform-1:5) 0.61
(acetone:benzene-1:1)

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明のサンゲノン化合物の赤外吸収スペクト
ル(rLtL)ol)を示す図、第2図は本発明のサン
ゲノン化合物の紫外吸収スペクトル(メタノール中)を
示す図である。 特許出願人 全薬工業株式會社 特許出願人代理人 特許出願人代理人
FIG. 1 is a diagram showing the infrared absorption spectrum (rLtL)ol) of the sungenone compound of the present invention, and FIG. 2 is a diagram showing the ultraviolet absorption spectrum (in methanol) of the sungenone compound of the present invention. Patent applicant Zenyaku Kogyo Co., Ltd. Patent applicant agent Patent applicant agent

Claims (1)

【特許請求の範囲】 1)下記の物理的及び化学的性質を有するサンゲノン化
合物(サンゲノンD)0 (a)性 状:黄色反応 (A1分子1: 708(フィールド デソープション
 マススペクトルのM+より) (C)融 点:175〜185℃ (分解)(d)比旋
光度: Ca〕v−145°(C=0.173、ytり
/−ル)(り赤外吸収スペクトル(n1L)’ol) 
 (α−1)シr、Laヨ:3200.1665(zh
 )、1645 (sh )、1620 (br、 )
、1555 (sh )(力紫外吸収スペクトル(n 
) λ0H3°H(log e ): 220 (sh、4
.65 )、226(、t=A、4.57)、maよ 283 (4,33)、288(lh、4.32)、3
09(4,30)  ’ λ2νH+klC1s (e、gε) : 225 (
4,62)、292 (、rA、4.28)309 (
4,39)、352(SA、3.94)400 (J?
h、 3.38 ) (y)呈色反応 塩化第二鉄反応     陽性 塩醗−マグネシウム反応   陽 性 水素化ホウ素ナトリウム反応     陽 性(勾溶媒
に対する溶解性 SS:水、ヘキサン、ベンゼン、クロロホルム、ジクロ
ロメタン °可溶 :エチルエーテル、酢酸エチル易溶: メタノ
ール、エタノール、ジメチルホルムアミ ド、アセトン (t)酸性、中性、塩基性の区別:#性2)クワ属植物
を極性溶媒で抽出し、その抽出物をシリカゲルカラムク
ロマトグラフィー、次いで分取薄層クロマトグラフィー
を行なうことにより得られる特許請求の範囲第1項記載
のサンゲノン化合物。
[Claims] 1) Sangenone compound (Sangenone D) 0 having the following physical and chemical properties (a) Properties: Yellow reaction (A1 molecule 1: 708 (from M+ in field desorption mass spectrum) (C) Melting point: 175-185°C (decomposition) (d) Specific optical rotation: Ca] v-145° (C = 0.173, )
(α-1) Shir, Layo: 3200.1665 (zh
), 1645 (sh), 1620 (br, )
, 1555 (sh) (power ultraviolet absorption spectrum (n
) λ0H3°H (log e): 220 (sh, 4
.. 65), 226 (, t=A, 4.57), mayo283 (4,33), 288 (lh, 4.32), 3
09(4,30)' λ2νH+klC1s (e, gε): 225 (
4,62), 292 (, rA, 4.28) 309 (
4,39), 352 (SA, 3.94) 400 (J?
h, 3.38) (y) Color reaction Ferric chloride reaction Positive Salt-magnesium reaction Positive Sodium borohydride reaction Positive (Solubility in gradient solvent SS: water, hexane, benzene, chloroform, dichloromethane ° Soluble: Ethyl ether, ethyl acetate Easily soluble: Methanol, ethanol, dimethylformamide, acetone (t) Distinction between acidic, neutral, and basic: #2) Extract Morus plants with a polar solvent; The sungenone compound according to claim 1, which is obtained by subjecting the compound to silica gel column chromatography and then preparative thin layer chromatography.
JP56141310A 1981-09-08 1981-09-08 Sangenone Granted JPS5841894A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56141310A JPS5841894A (en) 1981-09-08 1981-09-08 Sangenone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56141310A JPS5841894A (en) 1981-09-08 1981-09-08 Sangenone

Publications (2)

Publication Number Publication Date
JPS5841894A true JPS5841894A (en) 1983-03-11
JPH0228597B2 JPH0228597B2 (en) 1990-06-25

Family

ID=15288915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56141310A Granted JPS5841894A (en) 1981-09-08 1981-09-08 Sangenone

Country Status (1)

Country Link
JP (1) JPS5841894A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61291526A (en) * 1985-06-19 1986-12-22 Osaka Chem Lab Food for preventing adult disease and produced from mulberry and/or related species thereof
JPS62163732A (en) * 1986-01-16 1987-07-20 Mitsubishi Heavy Ind Ltd Simultaneous treatment of nitrogen oxide and carbon monoxide contained in exhaust gas

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61291526A (en) * 1985-06-19 1986-12-22 Osaka Chem Lab Food for preventing adult disease and produced from mulberry and/or related species thereof
JPS62163732A (en) * 1986-01-16 1987-07-20 Mitsubishi Heavy Ind Ltd Simultaneous treatment of nitrogen oxide and carbon monoxide contained in exhaust gas

Also Published As

Publication number Publication date
JPH0228597B2 (en) 1990-06-25

Similar Documents

Publication Publication Date Title
Zhao et al. Six new eremophilane derivatives from two Ligularia species
DK164866B (en) PROCEDURE FOR INSULATING ISOSILYBIN-FREE SILIBININE
JP4309769B2 (en) Novel glucopyranoside, separation method thereof, drug containing the same and method of use thereof
JPS5841894A (en) Sangenone
JP2005179339A (en) New compound and medicinal composition
Nyandat et al. The 7, 7 ″-β-diglucoside of (2S, 3R)-chamaejasmin from Ormocarpum kirkii
JPS58150584A (en) Kuwanon compound
JPS58150538A (en) Kuwanon compound
EP1732875B1 (en) Process for isolation of hepatoprotective agent &#34;oleanolic acid&#34; from lantana camara
JPH0260680B2 (en)
JPH0228596B2 (en)
JPS5843990A (en) Kuwanon compound
US6884908B2 (en) Process for isolation of hepatoprotective agent “oleanolic acid” from Lantana camera
Rogachev et al. Some prenylated phenols of Rhododendron adamsii: isolation, modification and pharmacological tests
JPH0114232B2 (en)
Patton et al. Quinoxaline Studies. III. The Preparation and Physical Properties of Some 2, 3-Dialkoxyquinoxalines
Kon et al. 114. Sapogenins. Part VIII. The sapogenin of Fuller's herb
JPS5857383A (en) Novel flavonoid
JP2585661B2 (en) Terpene compound and method for producing the same
JPS6287591A (en) Novel quassinoids and their preparation
JPS61189290A (en) Novel cistanoside compound and production thereof
JPS595176A (en) Antitumor agent
JPS6172719A (en) Anti-hyperlipemia
JPH01207298A (en) Prost-13(17)ene-3,16-dione compound
JPH01230593A (en) Swertiamarin